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Abstract
Basic research in the biomedical field generates both knowledge that has a
value   regardless of its possible practical outcome and that has the per se
potential to produce more practical benefits. Policies can increase the benefit
potential to society of basic biomedical research by offering various kinds of
incentives to basic researchers. In this paper we argue that soft incentives or
“nudges” are particularly promising. However, to be well designed, these
incentives must take into account the motivations, goals and views of the basic
scientists. In the paper we present the results of an investigation that involved
more than 300 scientists at Harvard Medical School and affiliated institutes.
The study shows that basic researchers’ support for soft incentives is such that
the transformative value of fundamental investigations can be increased
without affecting the spirit of the basic research and scientists’ work
satisfaction. After discussing the findings, we suggest a few examples of
nudges and discuss one in more detail.
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Basic or fundamental research—generally defined as untargeted   
research seeking to expand knowledge—is a key component of 
innovation. While it generates knowledge that has a value per se 
regardless of its possible practical outcome, it also delivers knowl-
edge that has the potential to produce more practical benefits1. Basic 
biomedical research in particular is crucial in addressing the chal-
lenges we face in our highly interconnected planet in which com-
municable diseases spread quickly and in which non-communicable 
diseases cause the premature death of many individuals2.
Historically, a wide range of basic biomedical research projects 
have contributed to the advancement of knowledge, from research 
solely inspired by the researcher’s curiosity to projects driven by a 
vision of how knowledge generated by research could be used as the 
basis for applied research. All research along this continuum is con-
sidered “basic” because it serves as the foundation for further research 
that may lead to applications. Scientific knowledge is produced by the 
coming together of all kinds of research streams and ideas. Abraham 
Flexner captured this aspect of science in the image of the Mississippi 
river, which “begins in a tiny rivulet in the distant forest. Gradually 
other streams swell its volume. And the roaring river that bursts the 
dikes is formed from countless sources”3. Although it often takes 
decades to develop, the applied outputs of knowledge advancement 
(e.g. drugs) have at their roots countless basic investigations.
Given its importance, complexity and breadth, basic research has 
been primarily funded by public money. This was particularly true 
in the decades that followed World War II and during which basic 
research went through a “golden age,” being conducted primarily in 
research universities and paid for with public money4. Sadly, public 
expenditure for research has decreased since then and nowadays 
fundamental sciences are for the most part underfunded. Basic bio-
medical research currently receives less support than it received 
only a few years ago. For instance, in the United States, National 
Institutes of Health (NIH) funding has been nearly stationary since 
2003 in the face of rapid expansion of research activity in existing 
biomedical fields and the emergence of new ones1. One explana-
tion of the low support for fundamental sciences is our cognitive 
bias in favor of immediate rewards. As our brains are structured in 
a way that leads us to unduly favor immediate rewards over future 
benefits5, we tend to underestimate the importance of human activi-
ties and initiatives with benefits that lie in the future6. Furthermore, 
basic researchers are said to owe a moral duty to extract maximum 
transformative value (the potential to translate into novel and fruit-
ful applied research) whenever their research is publicly funded7,8. 
In an effort to maximize transformative value of research, funding 
agencies like the NIH already take in some consideration the health 
benefit potential or (social) “significance” of a research proposal 
when assigning resources.
Assessing the societal impact of fundamental sciences is however 
more easily said than done. The topic is debated in the scientific 
and political communities9. Some policies already try to achieve 
this goal. Those based on strong financial incentives, such as the 
Bayh-Dole Act in the United States are already being used but 
they raise concerns as to whether monetary incentives distract 
basic scientists from focusing on fundamental questions10,11. New 
strategies to successfully maximize the transformative value of 
basic research without compromising the nature of fundamental 
inquiries are certainly needed. Softer incentives, which are called 
by behavioral economists “nudges”12, seem particularly promis-
ing as they have been successfully used in public health but not 
yet in basic research. If properly designed for basic research, 
nudges would slightly (and sometimes unperceivably) reorient 
some scientists in a certain direction without imposing rules or 
decreasing work satisfaction. However, these “nudges” can be   
designed well for basic research only if we have a good grasp of 
what motivates the basic scientists, what their values are and the 
intellectual frameworks in which they operate so that the proper 
soft incentives can be tailored around the particular characteristics 
of basic scientists.
In an effort to improve our understanding of basic scientists’ motiva-
tions, we designed a study to collect data from basic scientists at 
Harvard Medical School and affiliated institutions. We designed a 
survey that was filled out by more than 300 scientists. In the next 
sections, we present the results of this study and a discussion on how 
these findings can be used to increase the transformative value of 
basic biomedical research without decreasing the “basic” nature of 
these investigations and the motivations and freedom of the scien-
tists. Finally, we suggest a few examples of nudges and discuss one 
in more detail.
Results
Description of the survey and the sample
The survey was designed as an online questionnaire comprised of   
17 questions (Q1–Q17). On average, fewer than 2% of the respond-
ents, with a range from 0% (Q2 and Q3) to 6.3% (Q15) skipped 
any of the 17 questions. Answers could be provided through multi-
ple choices or, alternatively, textboxes for alphanumerical entries (see 
Methods section for additional details). 304 scientists took the survey. 
The first four questions of the questionnaire (Q1–Q4) gathered data 
on the sample characteristics. The first question (Q1) (all ques-
tions hereinafter will be referred to as Q#) aimed at identifying the   
respondent’s academic position: 39.9% declared themselves to be 
principal investigators, 34.7% to be post-docs, 10.6% to be PhD stu-
dents and 14.9% to belong to other categories (including “research 
assistants” and “research technicians”) (Figure S1). Q2 focused on 
gender. The sample’s gender distribution turned out to be 42.1%   
females and 57.9% males (Figure S2). Q3 asked  respondents to 
quantify the amount of their research time allocated to research that 
they consider to be “basic”. On average, respondents reported spend-
ing 76.3% of their research time on basic research (Figure S3), with 
only 3.6% of respondents stating that they were not involved (0%) 
in basic research. In order to test respondents’ commitment to basic 
research in general, Q4 asked them if they agreed/disagreed with 
the following statement: “Despite the current economic situation, 
public funding for basic biological/biomedical research should 
be increased”. 92.4% of the respondents agreed with the previous 
sentence while only 7.6% disagreed (Figure S4). Overall, these   
results show that our purposive sample was well balanced with   
regard to academic position and gender and that the surveyed sci-
entists were significantly involved in basic investigations and (for 
the great majority) supportive of increased public funding for basic 
biological/biomedical research.
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goal of publicly funded basic BIOLOGICAL (not biomedical)   
research be?” Respondents had three options. 71.7% responded 
“pure advancement of knowledge, regardless of future applicability”, 
21.9% responded “health benefit to the society (not necessarily in 
the near future)” and 6.4% responded that the most important goals are 
“other”, such as the “environmental or economical benefit to society” or 
“sustainability of our species and of the biosphere” (Figure 1C). Simi-
larly, Q10 asked the following question: “What should the most   
important goal of publicly funded basic BIOMEDICAL research 
be?” Interestingly, we had a very different outcome. Only 8.6% of 
the respondents answered “pure advancement of knowledge regard-
less of future applicability”, while 85.7% answered “health benefit 
to society (not necessarily in the near future)” and 5.6% answered 
that the most important goals are “other” (Figure 1D).
Thus, these results clearly indicate that most scientists think that 
considering the indirect practical outcome of basic scientific inves-
tigations is compatible with the notion of basic research. In other 
words, basic research should not be conceptualized as being nec-
essarily (or solely) driven by curiosity. Furthermore, these results 
suggest that scientists perceive the goals of “biological research” 
and “biomedical research” to be different, with a propensity to   
include health benefit to society as an important goal of biomedical 
research only.
Basic scientists think that considering the practical benefits of 
their research is compatible with the notion of basic science
The way scientists conceptualize basic research is important not 
only to define the concept but also to design policies that can   
effectively promote it. To this purpose, we asked a few questions to 
define the concept and goals of basic research. Q5 asked respond-
ents to express their level of agreement with the following: “basic 
research can be defined as the research that is not intended to yield 
immediate practical benefits except for advancement of knowledge”. 
Survey participants had four options to choose: complete agree-
ment, some agreement, some disagreement and complete disagree-
ment. 32.5% of the respondents expressed complete agreement, 
43.4% some agreement, 17.5% some disagreement and 6.6% 
complete disagreement (Figure 1A). To corroborate the responses 
of Q5, we designed a complementary question (Q6) to determine the 
level of agreement on the following: “basic scientists can ponder 
about the future indirect practical benefits of their research without 
losing their “basic status””. 71.2% of the respondents expressed 
complete agreement, 23.2% some agreement, 5.0% some disagree-
ment and 0.7% complete disagreement (Figure 1B). The results of 
Q6 were therefore in agreement with the results of Q5.
We also designed two questions (Q9 and Q10) to understand what 
should be the “goals” of biological and biomedical research accord-
ing to the basic scientists. In particular, Q9 asked respondents to   
Figure 1. How do scientists conceptualize basic “bio” research? (A) Graph shows the levels of agreement to the following statement: “Basic 
research can be defined as the research that is not intended to yield immediate practical benefits except for advancement of knowledge”. 
302 scientists answered the question; 2 skipped. (B) Graph shows the levels of agreement on the following statement: “Basic scientists 
can ponder about the future indirect practical benefits of their research without losing their “basic status””. 302 respondents answered the 
question; 2 skipped. (C) Graph shows how scientists answered the following question: “What should the most important goal of publicly 
funded basic BIOLOGICAL (not biomedical) research be?”. Surveyed scientists were given the indicated three choices. 297 answered the 
question; 7 skipped. (D) Graph shows how scientists answered the following question: “What should the most important goal of publicly 
funded basic BIOMEDICAL research be?” Surveyed scientists were given the indicated three choices. 301 answered question; 3 skipped.
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ately important”, “important” and “very important”) for six motiva-
tions. The rating average was then calculated after assigning a score 
from 1 to 5, to these five options. Scientists were therefore asked 
to provide feedback on the following (Q7) “the motivations of most 
What motivates the basic scientists?
Understanding the motivations of people is important for designing 
policies that offer incentives to pursue certain goals. We therefore 
designed two questions to gather information on what motivates-
basic scientists. The respondents were asked to select their level of   
Figure 2. What does motivate the basic scientists? (A) Graph shows the responses of the surveyed scientists to the following input: “the 
motivation of MOST basic biological/biomedical scientists are from:”. Six different types of motivations were proposed. Respondents could 
rate each type of motivation as “not a motivation, “minimally important”, “moderately important”, “important” or “very important”. Rating 
averages for each type of motivation are also indicated (the scores were 1 to 5, from “not a motivation” to “very important”). 299 respondents 
answered the question; 5 skipped. (B) Graph shows the responses to the following input: “YOUR personal motivations as a scientist are 
from:”. Six different types of motivations were proposed. Respondents could rate each type of motivation as “not a motivation, “minimally 
important”, “moderately important”, “important” or “very important”. Rating averages for each type of motivation are also indicated (the scores 
were 1 to 5, from “not a motivation” to “very important”). 302 respondents answered the question; 2 skipped.
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of “health benefit to society (not necessarily in the near future)” and 
less motivated from the “gain of prestige” and “gain of money” than 
the average scientist.
Most basic scientists think that estimating the potential future 
health benefits to society from basic biological/biomedical 
research is possible
To design policies to increase the practical impact of basic biomedical/
biological research, it is first important to understand whether 
estimating the health benefit potential of basic research is in any 
way feasible, a topic that has being debated for many years9. We 
gathered feedback on this issue by asking respondents to express 
their level of agreement on scientists’ ability to estimate the poten-
tial future health benefits at different stages of the research pro-
cess. Q11 stated: “Although it is difficult to assess the potential 
future health benefits to society from basic biological/biomedical 
research as described in written PROPOSALS, some degree of   
estimation is always possible”. 16.7% of the respondents were in 
complete agreement with this sentence, 57.7% in some agreement, 
19.0% in some disagreement and 6.7% in complete disagreement 
(Figure 3A).
basic biological/biomedical scientists are from:”. The rating average, 
for the motivation “pure advancement of knowledge, regardless of 
future applicability” was 3.91. The rating average for “health benefit 
to society (not necessarily in the near future)” was 3.93. The rating   
average for “gain of prestige” was 3.43. The rating average for 
“gain of money” was 2.42. The rating average for “satisfaction of 
their curiosity” was 4.24. The rating average for “satisfaction from 
solving puzzling problems” was 4.21 (Figure 2A).
To see if scientists perceive themselves differently from other scientists, 
we also asked respondents to provide feedback on the following input 
(Q8): “YOUR personal motivations as a scientist are from:”. The rating 
average for “pure advancement of knowledge, regardless of future 
applicability” was 3.82. The rating average for “health benefit to 
society (not necessarily in the near future)” was 4.32. The rating 
average for “gain of prestige” was 2.79. The rating average for 
“gain of money” was 2.29. The rating average for “satisfaction of 
their curiosity” was 4.18. The rating average for “satisfaction from 
solving puzzling problems” was 4.16 (Figure 2B). Thus, these results 
show that, with the exception of “gain of money”, all other moti-
vations are from “moderately important” to “very important” for 
more than 50% of the respondents. Moreover, these results show 
Figure 3. Most scientists think it is possible to estimate future health benefits potential of basic research. (A) Graph shows the levels 
of agreement on the following statement: “Although it is difficult to assess the potential future health benefits to society from basic biological/
biomedical research as described in written PROPOSALS, some degree of estimation is always possible”. 300 scientists answered the 
question; 4 skipped. (B) Graph shows the levels of agreement on the following statement: “Although it is difficult to assess the potential future 
health benefits to society from the RESULTS and FINDINGS of basic biological/biomedical research, some degree of estimation is always 
possible” 300 answered the question; 4 skipped.
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35.0% were in partial agreement, 35.0% were in partial disagree-
ment and 17.7% were in complete disagreement (Figure 4A).
We also proposed two questions with the purpose to shed light on 
how scientists would improve current funding criteria. In Q14, 
we asked to answer the following question: “What percentage of 
public funding should be allocated to basic biological/biomedical   
research proposals in which discussing the potential of future 
health benefits to society is not required?” According to the scien-
tists of our sample, 41.6% of public funding, on average, should be 
allocated to research in which a discussion of the potential health 
benefits is not required in written proposals (Figure 4B) (stand-
ard deviation was 25.72; 3.4% of the respondents to this question   
declared 0%; 6.6% of the respondents declared 100%).
In Q15 we asked respondents to answer the following question: 
“With regard to basic biological/biomedical research proposals in 
which discussing the potential of future health benefits to society 
is required, what average weight should be given to this potential 
in assigning scores for funding decisions?” The average “weight” 
Q12 stated: “Although it is difficult to assess the potential future 
health benefits to society from the RESULTS and FINDINGS of 
basic biological/biomedical research, some degree of estimation is   
always possible”. 22.0% of the respondents were in complete agree-
ment with this sentence, 61.0% in some agreement, 15.0% in some 
disagreement and 2.0% in complete disagreement (Figure 3B). 
These results therefore show that the majority (83%) of the sur-
veyed scientists think that estimating the future health benefits to 
society from the proposals or outcome of basic biological/biomedical 
projects is realistically feasible.
Most basic scientists think that the discussion of potential 
medical benefits in basic research proposals is not useful
Funding agencies around the world commonly request that the   
potential health benefits of basic research projects are discussed in 
the written proposals. In order to understand what scientists think 
about this requirement, Q13 asked respondents to express their level 
of agreement in the following statement: “Written proposals about 
basic biological/biomedical research generally contain a section 
discussing potential future health benefits. These sections increase 
the likelihood that a project benefits future public health”. 12.3% 
Figure 4. Scientists think more scientific projects should not be asked about their practical outcome potential. (A) Graph shows the 
levels of agreement on the following statement: “Written proposals about basic biological/biomedical research generally contain a section 
discussing potential future health benefits. These sections increase the likelihood that a project benefits future public health”. 300 scientists 
answered the question; 4 skipped. (B) Graph shows how surveyed scientists responded to the following question: “What percentage of public 
funding should be allocated to basic biological/biomedical research proposals in which discussing the potential of future health benefits 
to society is not required?”. 290 answered the question; 14 skipped. (C) Graph shows how surveyed scientists responded to the following 
question: “With regard to basic biological/biomedical research proposals in which discussing the potential of future health benefits to society 
is required, what average weight should be given to this potential in assigning scores for funding decisions?” 285 answered the question;   
19 skipped.
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Interestingly, we noticed that principal investigators were significantly 
more in disagreement than post-docs (63.4% and 41.2%, respectively) 
with regard to the effectiveness of this policy in increasing societal 
benefits (Figure S5). Moreover, scientists believe that a considerable 
indicated by the scientists of our sample was 35.7% (Figure 4C) 
(standard deviation was 25.87; 6.7% of the respondents to this 
question declared 0%). Thus, this set of results indicates that the 
majority of scientists think that discussing the potential future 
health benefits in basic research proposals is not an effective way to   
Figure 5. Most scientists are in favor of motivational incentives to increase the health benefit potential of their investigations. (A) 
Graph shows the levels of agreement on the following statement: “Motivational INCENTIVES, which are not based on restrictive policies such 
as the requirement to discuss the potential of future health benefits, CAN increase the degree to which basic biological/biomedical research 
is likely to benefit the future health of society”. 293 answered the question; 11 skipped. The incentives were proposed either as financial or 
as non-financial. (B) Graph shows the levels of agreement on the following statement: “Motivational INCENTIVES, either “in addition to” or “in 
substitution of” restrictive policies, SHOULD be used to increase the degree to which basic biological/biomedical research is likely to benefit 
the future health of society”. 294 answered the question; 10 skipped. The incentives were proposed either as financial or as non-financial.
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and 12.4% in complete disagreement (Figure 5B). Thus, these   
results suggest that the vast majority of basic scientists are in favor 
of motivational incentives (either financial or non-financial) to be 
used either “in addition to” or “in substitution of” more restrictive 
policies to increase the public health potential of basic biological/
biomedical research.
Summary of results
The majority of the scientists who participated in the survey indi-
cated that the most important goal of publicly funded basic bio-
medical research is the production of health benefits to the society 
(86%) (Figure 1D) and that the desire to effectively benefit soci-
ety is an important or very important motivation for most of them 
(87%) (Figure 2B). While the benefits to society may be not real-
ized in the near future, a substantial majority of respondents (74%) 
(Figure 3A) agreed/partially agreed on the idea that some degree of 
estimation of the potential contribution to human health is possible 
for every basic research proposal. Further, they indicated that, ide-
ally, more than half of public funding should be allocated to pro-
posals in which a discussion of the potential future health benefits 
to society is required. Moreover, with regard to the definition of 
basic research, nearly all respondents (94%) (Figure 1B) indicated 
that thinking about the future practical benefits of their research 
is compatible with the status of “basic” researchers, thus implying 
that basic research should not be conceptualized as (necessarily or 
solely) driven by curiosity.
Our data also shed a light on scientists’ motivations (besides con-
tributing to health benefit to society). This information is useful 
to design incentive-based policies. Our survey confirmed that the   
so-called “puzzle-motivation”—the satisfaction from solving puzzling 
problems—was an important motivator13 for almost all basic scien-
tists (among our respondents 93% said that “satisfaction from solv-
ing puzzling problems” and 95% that “satisfaction of curiosity” were 
proportion of public funding (41.6%) should be allocated to   
research proposals in which discussing the future health benefits to 
society is not required.
Most basic scientists are in favor of motivational incentives 
to increase the likelihood that a research project benefits 
future public health
In order to understand if scientists believe that motivational incen-
tives could be more effective than stricter policies (such as the 
mandatory discussion of the potential medical benefits in research 
proposals), we asked (Q16) scientists to express the level of agree-
ment on the following statement: “Motivational INCENTIVES, 
which are not based on restrictive policies such as the requirement 
to discuss the potential of future health benefits, CAN increase the 
degree to which basic biological/biomedical research is likely to 
benefit the future health of society”. With regard to financial incen-
tives, 18.4% of the respondents were in complete agreement with 
this statement, 53.9% in some agreement, 16.0% in some disa-
greement and 11.6% in complete disagreement. With regard to 
non-financial incentives (e.g. awards, recognition), 13.5% of the 
respondents were in complete agreement with the statement, 60.6% 
in some agreement, 17.3% in some disagreement and 8.7% in com-
plete disagreement (Figure 5A).
To understand if motivational incentives should be implemented 
and used, we also asked respondents (Q17) to express the level of 
agreement on the following slightly different statement: “Moti-
vational INCENTIVES, either “in addition to” or “in substitution 
of” restrictive policies, SHOULD be used to increase the degree to 
which basic biological/biomedical research is likely to benefit the 
future health of society”. With regard to financial incentives, 15.4% 
of the respondents were in complete agreement with this statement, 
47.1% in some agreement, 20.8% in some disagreement and 16.7% 
in complete disagreement. With regard to non-financial incentives, 
14.1% of the respondents were in complete agreement with the 
Figure 6. Working model to increase practical benefit to society. In order to increase the health benefits to society from basic “bio” 
research, policies should produce a good integration between basic and applied investigations and maximize transformative value of basic 
science. The directions of the arrows are intended only to express the capacity of transformative value of research (arrows pointing towards 
the top vertex of the triangle have maximum transformative value) and are not intended to reflect neither the quality of research nor the status 
of “basicness”.
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good reputation and a role in benefiting society.
Box 1. Example of nudges (“soft” motivational incentives) 
potentially useful to increase the transformative value of basic 
research without altering its fundamental nature and its volume.
  •  Locating basic research laboratories in proximity of hospitals
  •  Organizing educational meetings between scientists and the  
  general public or patients associations. Acknowledging the  
  participating scientists. Considering their participations    
  during grant assignments, promotion, hiring etc.
  •  Organizing more seminars (in academia and outside) about  
  the role of scientific research and scientists in the society
  •  Recognizing the work of basic scientists in producing    
  health benefits e.g. Requiring a list of seminal basic research  
  articles for each new drug, medical device or other biological  
  applications (see text for more details)
  •  Promoting more discussion on the concept and definition of  
  basic research
  •  Different conceptualization of the notion of basic research 
  (see text for more details)
A model of such an incentive would be to formally recognize the 
basic scientists when new drugs or medical devices are approved, 
as we recently proposed14. This type of incentive would make use of 
the “ribbon-motivation” but without undermining the “puzzle-moti-
vation” or research freedom generally13. This system could work by 
implementing a “bibliography of basic papers” for each newly ap-
proved drug. To apply this idea, a peer review group would identify 
the basic papers that have been influential for the development of 
the drug (or other biological applications) or, alternatively, review 
a list proposed by the drug owner14. A list of fifty to one hundred 
basic research papers would be selected and appear in the public 
databases (such as the Orange Book of the FDA) and in the drug 
package. This system would be a “weak attractor” because it would 
not distract scientists from basic research but it would represent a 
small, mostly unconscious, incentive to pursue research lines that 
can more easily lead to future drugs. Therefore this system would 
not dramatically affect the whole “ecosystem” of the scientific 
research that indeed needs to be made of a balanced mix of the 
different types of research, from the “purely” basic to the “purely” 
applied (Figure 6). This method would also present the advantage of 
increasing public awareness of the role of basic science, which we 
think is often underestimated by lay people as well as politicians.
Moreover, we believe that a different conceptualization of the   
notion of basic research would help in increasing the transforma-
tive values of fundamental investigations. A portion of basic research 
should (continue to) be devoted to purely curiosity-driven purposes as 
knowledge per se has a value and increases the quality of life of people 
through fascination and ‘soul nourishment’. However, basic research 
should not be conceptualized as solely driven by curiosity. Indeed, in 
our survey, nearly all respondents (94%) (Figure 1B) indicated that 
thinking about the future practical benefits of their research is com-
patible with the status of “basic” researchers. Therefore, similar 
to the Organisation for Economic Co-operation and Development 
(OECD)’s division of the continuum of basic research into pure   
from “moderately” to “very important” motivations) (Figure 2B). 
The so-called “ribbon-motivation”—the gain of prestige and 
recognition—was significantly more important than the gain of per-
sonal money (among our respondents 60% said that the “gain of 
prestige” was a “moderately” to “very important” motivation for 
them compared to 41% who said the same for the “gain of money”) 
(Figure 2B). Moreover, the majority of respondents of the survey 
were in favor of using financial incentives (62%) and non-financial 
incentives (70%) to increase the degree to which basic biological/
biomedical research is likely to benefit the future health of society 
(Figure 5B).
Responses of Harvard Medical School (and affiliate) scientists 
to an online survey on basic and biomedical science policy
2 Data Files
http://dx.doi.org/10.6084/m9.figshare.902837
Discussion
The results of this survey provide valuable information to help 
conceive new effective policies to increase both the health benefit 
potential of basic biological and biomedical research and the work 
satisfaction of scientists without altering the nature and volume of 
scientific investigations (schematized in Figure 6). Building on 
these results, we conclude that nonfinancial soft incentives (nudges), 
in particular, are perceived as valuable tools to maximize the trans-
formative value of basic research as they would not entail much 
work for scientists and can be implemented without significantly 
increasing public spending and bureaucratic burden. We also   
believe that soft incentives would be a valuable departure from 
current policies, which according to the scientists surveyed in our 
study, are ineffective. Indeed, despite 92% of respondents indicat-
ing that they are in favor of an increase in public funding for basic 
biological/biomedical research (Figure S4), a significant majority 
of the principal investigators (63%) (Figure S5) declared that the 
sections in written proposals aimed at discussing the potential 
future health benefits do not really increase the likelihood that a 
project will benefit future public health. Scientists also claimed that 
more public funding (on average the 42% of the total public fund-
ing committed to basic biological/biomedical research) should be 
devoted to basic biological/biomedical research proposals in which 
discussing the potential of future health benefits is not required 
(Figure 4B).
Based on these findings, we propose a few examples of policies 
based on soft (sometimes subconscious) incentives that could gently 
direct some scientists towards undertaking basic research inquiries 
with higher transformative value (Box 1). One example would be 
placing research laboratories in the proximity of hospitals to expose 
basic scientists to the view of patients and practicing physicians.   
Another one would be organizing more (non-mandatory) educational 
meetings in which scientists explain their work to the general public 
or to associations of patients (giving credit to the participating scien-
tists). A similar proposal would be organizing periodical seminars 
inside research institutions to discuss the role of scientific research 
and scientists in society. Indeed we believe that effective policies 
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F1000Research 2014, 3:20 Last updated: 25 APR 2014(Q1–Q17) plus one additional field for free comments. Answers could 
be provided through multiple choices or, alternatively, textboxes for 
alphanumerical entries. Each single question had the option to be 
skipped. The survey was sent to a sample of scientists involved 
in basic biological/biomedical studies (for the most part, cell and   
molecular biology studies). The scientists were also asked to con-
firm their level of involvement in basic fundamental research (see 
results section). The responses were collected during 9 consecutive 
weeks during 2012 (end of April to the end of June). Principal investi-
gator (PI) scientists were contacted by email after consulting the web-
sites of Harvard University and some affiliated institutes (Brigham 
and Women’s Hospital, Beth Israel Deaconess Medical Center, 
Dana-Farber Cancer Institute, Joslin Diabetes Center and Children’s   
Hospital); the majority of principal investigators were asked to 
forward the survey to members of their own groups. Post-docs were 
contacted either by their PIs or by using university-associated mailing 
lists and networking. Also a few scientists with other types of posi-
tion (e.g. PhD students, instructors, research assistants) took part 
in the survey, generally contacted by their PIs. In addition to the 
specific request to forward the survey to their own groups or to close 
intra-institutional colleagues, the contacted scientists were specifi-
cally asked not to forward the survey to the outside community. The 
survey was completely voluntary and anonymous.
Data availability
Figshare: Responses of Harvard Medical School (and affiliate) 
scientists to an online survey on basic and biomedical science policy, 
http://dx.doi.org/10.6084/m9.figshare.90283716.
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basic research and oriented basic research (http://stats.oecd.org/
glossary/detail.asp?ID=192), we believe basic research can use-
fully be divided into two broad categories: solely curiosity-driven 
research and research driven by a vision of how the knowledge 
generated might be useful for future applications. In this context, 
the term “blue skies research”, sometimes used to define the entire 
field of basic research15 might be used for those studies that are 
solely (or largely) curiosity-driven. Even if curiosity does remain 
one of the main motivators for conducting and studying science, 
we believe that basic research should be conceptualized as research 
that focuses on basic mechanisms of natural phenomena rather than 
research that is intended to satisfy scientists curiosity (as it is fre-
quently presented in the mass media). Along these lines, we must 
also revisit the idea that since the future benefits of basic research 
cannot be accurately predicted, all basic research is equally valu-
able, i.e. every imaginable basic investigation would have the same 
exact potential of practical outcome. In fact, the great majority of 
scientists who took part in our survey pointed out that, despite the 
fact that it is usually necessary to undertake a very long pathway 
(the “countless sources” mentioned by Abraham Flexner3) before 
being able to funnel basic knowledge toward more applicative stud-
ies, some degree of assessment of the transformative value of basic 
investigations is always possible. It follows that since the potential 
benefits for society are roughly predictable, basic research can be 
evaluated prospectively; this does not lessen the “basic status” of 
either the research or the scientist. Such a revised mindset could 
“nudge” more basic scientists (and grant funders) to wonder about 
the future impact of their investigations.
Basic research advances knowledge that, regardless of its possible 
practical outcome, has a value per se. In addition, basic research has 
also the potential to produce more practical benefits to humanity, 
such as the prevention and treatment of diseases. As a society, we 
have the moral obligation to try to maximize this potential. We   
believe, and the data presented in the paper support, the idea that 
soft incentives can be valuable tools for increasing this potential 
without corrupting the spirit of fundamental investigations, thus 
further aligning the goals of cell and molecular biologists with 
those of the broader public health community.
Methods
Ethics statement: On April 2, 2012, the Institutional Review Board 
(IRB) of Harvard School of Public Health determined that the pro-
posed study meets the criteria for exemption per the regulations 
found at 45 CFR 46.101(b)2. The IRB made the following determina-
tions: Research Information Security Level; the research is classified, 
using Harvard’s Data Security Policy, as Level 1 data. The notifica-
tion was signed by QA/QI specialist.
The survey was designed as an online questionnaire (powered by 
SurveyMonkey, www.surveymonkey.com) made of 17 questions 
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Figure S1. Academic positions of the surveyed scientists.
Figure S2. Gender distribution of the surveyed scientists.
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Males 57.9%
Answered question   304
Skipped question 0
Males
Females
Q2.
Are you?
Principal investigators 39.9%
Post-docs 34.7%
PhD students 10.6%
Other 14.9%
Answered question 303
Skipped question 1
Q1.
Please indicate which of the following best describes you:
PIs Post-docs
Students Other
Page 11 of 15
F1000Research 2014, 3:20 Last updated: 25 APR 2014Figure S3. Level of involvement in basic research of the surveyed scientists.
Figure S4. The vast majority of basic scientists think that public funding for basic biological/biomedical research should be increased, 
despite the current economic situation.
Q3.
Approximately, what percentage of your research do you consider to be basic?
Basic 76.29%
Answered question   304
Skipped question 0 Basic
Q4.
Despite the current economic situation, public funding for basic biological/biomedical 
research should be increased
I Agree 92.4%
I Disagree 7.6%
Answered question 302
Skipped question 2  I agree
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potential practical outcome in basic research proposals.
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Approved: 31 March 2014
 31 March 2014 Referee Report:
This study addresses an interesting and relevant topic. Box 1 in particular is innovative and makes a good
link to the findings.
 
I have the following comments:
More remarks are needed about the relevant body of evidence. Are there other studies that
investigated the self-understanding of basic scientists in biomedicine? The Background mentions
none and the Discussion only one paper.
 
The main text should make clear that the response rate and reasons for non-response are not
known. A brief explanation together with a justification on why this approach was selected should
be given.
 
Figure 6 is somewhat simplistic and packed with several unjustified assumptions on what the (true)
positive and negative effects of specific pattern of resource allocation to basic or translational
research are. This should be deleted. The legend to figure 6 is very general, for example the
recommendation saying that one should “produce a good integration between basic and applied
”. investigations …
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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  Giorgio Scita
IFOM, FIRC Institute of Molecular Oncology Foundation at IFOM-IEO Campus, Milan, Italy
Approved: 30 January 2014
 30 January 2014 Referee Report:
This is an interesting well-conducted study that clarifies the way basic science is perceived by basic
scientists.
It would have been interesting to assess whether the career stage of the respondents has any impact on
their answers to the survey.
In the discussion a point is raised as to whether there is the need to revisit “the idea that since the future
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In the discussion a point is raised as to whether there is the need to revisit “the idea that since the future
” based on benefits of basic research cannot be accurately predicted, all basic research is equally valuable
the finding that the majority of scientists believe that “some degree of assessment of the transformative
”. However in the absence of a clear definition of what the value of basic investigations is always possible
degree of assessment is, it remains difficult to fully support such a perception. Thus caution should be
exerted in drawing a conclusion as to whether this mindset could “nudge” more basic scientists (and grant
funders) to wonder about the future impact of their investigations.
The list of soft motivational incentives in BOX1 is thought provoking and stimulating.
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it is of an acceptable scientific standard.
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